Quest Diagnostics IncorporatedDGX

$195.00-2.76 (-1.40%)
NYSEHealthcare24:00 UTC

Company snapshot

Market Cap
$22B
Large-cap
+88%
2016 — today
10-Year Price
+141%
2016 — today
52-Week Range
$166.42$211.91
Current $195.00· 63%

Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.

Valuation in context

P/E ratio
21.5
Historically pricey
Historically pricey — last 10 years
P/B ratio
2.8
Historically pricey
Historically pricey — last 10 years
EV / EBITDA
13.4
Near historic high
Near historic highs — last 10 years
Dividend Yield
1.7%
Historically low
Historically low relative to the last 10 years
FCF Yield
6.1%
Around average
Around the 10-year average
Free · No credit card needed

Get alerted when DGX is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.